Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 8

Care Plan

Student: Alexandria Casarez Date: 03/01/2020

Course: 320 CC Instructor: Leigh Ann Tovar

Clincial Site: Banner Del Webb Client Identifier: BW Age: 78

Reason for Admission: Patient was addmited to the observation floor on 2/29/2020 due to nausea and vomiting, weakness, dehydration, and
diarrhea.

Medical Diagnoses: (Include Pathophysiology and Risk Factors): Clinical Manifestation(s):


The reason for admission for this patient discussed nausea and Clinical manifestation of a stroke includes affecting many body
vomiting and was resolved as of 3/1/20. The morning of the 1st functions. These bodily functions include motor activity, bladder
patient complained of difficulty swallowing. The medical and bowel elimination, intellectual function, spatial-perceptual
diagnosis related to the difficulty of swalowing is a channges, sensation, swallowing, and communication(Harding et.
cerebrovascular accident (CVA). A CVA can also be called a al, 2017). Depending which artery is affected can cause ischemia to
stroke, and it occurs when there is a interuption of blood flow to different parts of the brain and the clinical manifestations may be
the cranial tissues. Risk factors for stroke include modifyable and specific to that area of the brain.
nonmodifiable. The modifiable risk factors include hypertension,
heart disease, diabetes, smoking, obesity, poor diet, and drug and
alcohol use. The nonmodifiable risk factor include age, gender,
ethnicity, family history or hereditary (Harding et. al, 2017).

Assessment Data
Subjective Data: Patient was talkative and cooperative when talking with nurses and doctors. Patients patient expressed gratitue and comfort
to nursing staff while assisting her. Patient complained of pain in leg and arm related to left sided hemiplagia.
© 2018. Grand Canyon University. All Rights Reserved. Rev 2.17.18
VS: T : 36.4 ° C Labs: Diagnostics:
BP: 110/73 -Complete Blood Count No diagnostics were found in the patients chart that
related to the reason for admission.
HR: 104 RBC-4.42
RR: 18 WBC-8.3
O2 Sat: 99% on room air HGB-13.5
HCT-41.6%
MCV-94
MCH-30.5
MCHC-32.5
-Chem Gener
Glucose-150 mg/dL (H)
BUN-15
Creatinine-0.97
GFR-56 (L)
Na-141
K-3.5
Cl- 107
Co2-23
Anion Gap- 11
Ca-8.3 (L)

2
Assessment: Orders/Safety Protocols:

Neuro: Patient was alert and oriented x4 patients speech was clear and -ambulate with assistance
appropriate. Patients pupils were equal, round, reactive to light, and -full code
accommodation was notted. Eyes opened to verbal commands, and
patient had a cooperative affect. -precasutions for allergy to latex

Repiratory: Patients O2 was 99% on room air, patients lung sounds -fall precautions
were clear throughout all lobes with unlabored breathing.
-soft food diet
Cardo/ Vascular: Heart sounds were auscultated for all valves, S1 and
-patient has order to be NPO after midnight on 03/01/2020 @ 23:59
S2 were noted with regular rate and rhythm. Patients radial and pedal
MST
pulses were noted at 2+ bilaterally. Capillar refil was less that 3 seconds
in both fingers and toes. No edema was noted in the patients upper and
lower extremity.
GI: Patients stomach is flat, and non-tender, bowel sounds were
normoactive.
GU: Patient voids without pain and urine is a darker yellow and without
sediment, with a strong oder.
Skin: Patients skin appeared consistent with ethnicity, skin was intact,
and warm.
Hygine: Patient preforms parital bed bath on self as needed.
Pain: Patient does not complain of pain at the moment.
Lines and IV’s: Patient has a 20g IV catheter in right antecubital.

Medications
ALLERGIES: Patient has alergies to latex, no known drug allergies.

3
Name Dose Route Frequency Indication/Therapeutic Adverse Effects Nursing
Effect Considerations
Albuterol-ipratropium 3mL Nebulizer Q 6 hrs Used as a bronchodialator to Nervousness, restlessness, Assess lungs sounds,
(DuoNeb) control and prevent revirsible tremor, chest pains, palpatations, pulse, and BP before
airway obstruction. and arrythmias administrations and
throughout therapy.
Observe for paradoxical
bronchospasm.
Asprin 81 mg PO Daily Blood thinner, and fever Heart burn, bleeding, Monitor hepatic
reducer. hepatotoxicity, and anaphylaxis function and serum
levels for drug toxicity.
Atrovasatin 80 mg PO Q bedtime Secondary prevention of Amnesia, confusion, dizziness, Obtain a dietary history,
cardiovascular disease by HA, insomnia, abdominal especially with regards
decreasing risk of MI, stroke, cramps, constipation, diarrhea, to fat consuption.
and angina. heartburn, and blurred vision Instruct patient to take
the medicationas
directed, to not skip or
double up on doses.
Galbapentin 200 mg PO Daily Used for partial seizures or Suicidal thoughts, depression, Monitor closely for
neuropathic pain. confusion, anxiety, diziness, and notable changes in
hostility behavior that could
indicate a the
emergence of suicidal
thoughts or depression.
Levothyroxine 88 mcg PO Daily Thyriod suplementation in HA, insomnia, irritability, Assess apica lpulse and
hypothyriodism. abdominal cramps, arryhtmias, BP prior to and
tachycardia, sweating, and periodically durring
meanstrual irregularities therapy.
Assess for tachycardia
and chest pain.
Losartan 50 mg PO BID Lowers BPand slowed Dizziness, anxiety, depression, Assess patient for signs
progression of diabetic fatigue, HA, hypotension, and of angioedema.
neuropathy. chest pain
Mirtazapine (Remeron) 15 mg PO Q bedtime Major depressive dissorder. Drowsiness, dizziness, Monitor closely for
constipation, dry mouth, changes in behavior that

4
hypotension, weight gain, could indicate the
suicidal thoughts, and emargence or
agranulocytosis worsening of suicidal
thoughtsor behavior or
depression.
Montelukast 10 mg PO Q evening Prevention of chronic treatment Suicidal thoughts, agitation, Monitor closely for
of asthma. anxiety, agression, hallucination, changes in behavior that
HA, insomina, tremor, could indicate the
weakness, and abdominal pain emergence of eorsening
depression or suicidal
thoughts.
Asssess for rash
periodically throughout
therapy because this
medication may cause
Stevens-Johnson
syndrome.
Potassium chloride 10 mEq PO Q evening Maintain acid-base balance, Confusion, restlessness, Monitor pulse, BP, and
isotonicity, and weakness, abdominal pain, ECG periodically
electrophysiologic balance of nausea, vomiting, and arrythmias during IV therapy.
the cell.
Pramipexole 0.5 mg PO BID Decreased treamor and rgidity Sleep attacks, amnesia, diziness, Assess patient for signs
in Parkinson’s disease. drowsiness, hallucinations, of psychotic like
weakness, abnormal dreams, and behavior and risk for
confusion these symptoms
increased with age.
Ropinirole 1 mg PO Q evening Management of signs and Sleep attacks, diziness, syncope, Assess patient for
symptoms of idiopathic agitation, confusion, delerium, drowsiness and sleep
Parkinson’s disease. delusion, and impulse control attacks. Drowsineess is
disorder a comon side effect
Nursing Diagnoses and Plan of Care
Goal Expected Outcome Intervention(s) Rationale Evaluation
Client- or family-focused. Measurable, time-specific, Nursing or interprofessional Provide reason why intervention Was goal met? Revise the
reasonable, and attainable. interventions. is indicated/therapeutic. plan of care according the
Provide references. client’s response to current
plan of care.
Priority Nursing Diagnosis (including rationale for choosing this as the priority diagnosis)
Impaired physical mobility related to stroke as evidence by left sided hemiplegia.
5
The goal is to improve the Expected outcomes includes the Preforming ROM exercises to Preforming ROM exercises Evaluate if the paitent met
patient mobility and prevent any patient maintaining muscle joints unless contraindicatedat prevents joint contractures. the expected outcomes
further injury. strength and joint ROM, patient least once every shift. includng maintaining muscle
showing no further evidence of Identifying the level of mobility strenght and evaluate if the
complication, patient will Identify the level of functioning can establish a sense of patient achieved the highest
achieve highest level of using a functional mobility scale. continuity in the patients care. level of mobility.
mobility.
Place items within reach of the Palcing items within reach of
unaffected side of patient. patients unaffected side
promotes the patients
independence.

Secondary Nursing Diagnosis:


Risk for injury related to left sided hemiplagia.
The goal for this patient Expected outcomes for this Improve envirionmental safetey Improving safety will help Evaluate if the patient met the
includes identifying and paitent include ackowledging as needed including leaving bed patients cope with unfamiliar expected outcomes including
eliminating possible casues for the prescence of envirionmental at lowest level, teach patient to surroundings. acknowledging hazards and if
injury. hazards in their everyday use call light, and raising side the patient developed a strategy
surroundings and patient and rails when needed. to maintain their safety.
family will develop a strategy to
maintain safety. Helping identifying hazards can
Help the patient and their family increase the patients awareness
identify situations and hazrds to potential danger.
that can casue accidents.
Providing additional teaching
Provide additional patient helps the paitent take steps to
teaching as needed to include improve their safety.
household, automobile, and
pedestrian safety.

Definition of Client-Centered Care: Care that is unique to the age/developmental stage, gender, race, ethnicity, socioeconomic
status, and cultural and spiritual preferences of the individual and focused on providing safe, evidence-based care for the achievement
of quality client outcomes.

6
Reference:
Harding, M., Roberts, D., Reinisch, C., Haggler, D., Kwong, J. (2017). Lewis's Medical-Surgical Nursing. [Pageburstls]. Retrieved

from https://pageburstls.elsevier.com/#/books/9780323551496/

Phelps, L. (2017). Sparks and Taylor's nursing diagnosis reference manual (10th ed.). Hagerstown, MD: Lippincott, Williams &

Wilkins/Wolters Kluwer. ISBN-13: 9781496347817

7
Vallerand, A., Sanoski, C., & Deglin, J. (2017). Davis’s drug guide for nurses (15th ed.). 

Philadelphia, PA: F.A. Davis.

You might also like